Correction for you.
PE on ASX is based on profit, not gross sales EBOTI. So where you say 750 per unit... that is a gross sales price, and need to take all costs out of that first, then apply tax, then use the new figure ( I was using $200 ). And back convert to aud.
However, agree I think SP will be somewhere in the single digits by next year. I hope the company release the sales data so we can more or less compare success against Kaken.
Well done to everyone who held over that decision. It took some intestinal fortitude for sure, but in 5 years time I bet everyone will be looking at BOT graph saying, I wish I was able to purchase pre FDA approval!!
Now it's over to the team to smash sales out of the park. Keep an eye on the influencer scene to see how BOT fares in the marketing next quarter!
Get it Vince!!!!!
- Forums
- ASX - By Stock
- BOT
- Ann: FDA Approves Sofdra
Ann: FDA Approves Sofdra, page-240
-
- There are more pages in this discussion • 315 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.3¢ |
Change
-0.013(3.73%) |
Mkt cap ! $586.1M |
Open | High | Low | Value | Volume |
33.5¢ | 33.8¢ | 31.5¢ | $1.565M | 4.806M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 547903 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 40922 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 547974 | 0.320 |
20 | 794442 | 0.315 |
32 | 958220 | 0.310 |
15 | 684333 | 0.305 |
29 | 463827 | 0.300 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 39293 | 18 |
0.330 | 469379 | 9 |
0.335 | 255156 | 5 |
0.340 | 590253 | 11 |
0.345 | 401823 | 7 |
Last trade - 14.12pm 12/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online